09/09/2026 07:10
ANTIN INFRASTRUCTURE PARTNERS : Half yearly financial reports and audit reports/limited reviews / Terms of availability of the half-yearly financial report
HALFYEAR 2026 FINANCIAL REPORT NOW AVAILABLE Regulated information Paris, London, New York | 9 September 2026 Antin Infrastructure Partners has made available to the public and filed with the French Financial Markets Authority AMF its HalfYear 2026... Lire...
09/09/2026 07:05
EQS-News: TerraPay Connects its Wallet Interoperability Network, Xend to Alipay+, Strengthening Global Payments Interoperability
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: TerraPay / Key words: Joint Venture/Agreement br/ TerraPay Connects its Wallet Interoperability Network, Xend to Alipay, Strengthening Global Payments Interoperability... Lire...
09/09/2026 07:00
DocMorris AG : DocMorris launches private placement of approx. CHF 100 million Convertible Bonds due 2031 to finance early repurchase of Convertible Bonds 2028
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd pDocMorris AG / Key words: Bondbr/ DocMorris launches private placement of approx. CHF 100 million Convertible Bonds due 2031 to finance early repurchase of Convertible Bonds 2028 br/br/ 09Sep2026 / 07:00... Lire...
09/09/2026 07:00
Medacta Group SA: Medacta Group SA reports above-market revenue growth of 9.7% in constant currency1 with a robust adjusted EBITDA margin of 27.8% in c.c.1 in H1 2026
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd pMedacta Group SA / Key words: Half Year Results/Half Year Resultsbr/ Medacta Group SA: Medacta Group SA reports abovemarket revenue growth of 9.7% in constant currency1 with a robust adjusted EBITDA margin of... Lire...
09/09/2026 07:00
BioVersys reports half-year 2026 results: BV100 pivotal RIV-TARGET trial actively recruiting, alpibectir Phase 2b/c underway, operations funded into 2028
html xmlns=http://www.w3.org/1999/xhtmlbody table border= cellpadding= cellspacing=trtd pBioVersys AG / Key words: Half Year Resultsbr/ BioVersys reports halfyear 2026 results: BV100 pivotal RIVTARGET trial actively recruiting, alpibectir Phase 2b/c underway, operations... Lire...
09/09/2026 07:00
LAFARGEHOLCIM LTD : Holcim invests in Cloud Cycle to bring real-time machine learning to concrete delivery
html xmlns=http://www.w3.org/1999/xhtmlbody table border= cellpadding= cellspacing=trtd p Holcim Group Services Ltd / Key words: Investment br/ Holcim invests in Cloud Cycle to bring realtime machine learning to concrete delivery br/br/span09.09.2026... Lire...